# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA3813390 | Functional | Antiviral activity against HCMV AD169 assessed as inhibition of viral infection in human MRC5 cells by RT-qPCR method | Human betaherpesvirus 5 | 10 | ALA3808290 | organism-based format | Scientific Literature | |
2. | ALA3813393 | ADME | Half life of compound in human liver microsomes | Homo sapiens | 15 | ALA3808290 | tissue-based format | Scientific Literature | |
3. | ALA3813395 | Physicochemical | Solubility of the compound at pH 6.8 | 9 | ALA3808290 | small-molecule physicochemical format | Scientific Literature | ||
4. | ALA3813396 | ADME | Inhibition of CYP3A4 (unknown origin) | Homo sapiens | 9 | ALA3808290 | single protein format | Scientific Literature | |
5. | ALA3813397 | ADME | Inhibition of CYP2D6 (unknown origin) | Homo sapiens | 2 | ALA3808290 | single protein format | Scientific Literature | |
6. | ALA3813400 | ADME | Inhibition of CYP2C8 (unknown origin) | Homo sapiens | 6 | ALA3808290 | single protein format | Scientific Literature | |
7. | ALA3813401 | ADME | Inhibition of CYP2C9 (unknown origin) | Homo sapiens | 9 | ALA3808290 | single protein format | Scientific Literature | |
8. | ALA3813402 | Functional | Antiviral activity against HCMV TB40 assessed as inhibition of viral infection in human MRC5 cells by RT-qPCR method | Human betaherpesvirus 5 | 1 | ALA3808290 | organism-based format | Scientific Literature | |
9. | ALA3813403 | Functional | Antiviral activity against HCMV TR assessed as inhibition of viral infection in human MRC5 cells by RT-qPCR method | Human betaherpesvirus 5 | 1 | ALA3808290 | organism-based format | Scientific Literature | |
10. | ALA3813551 | Functional | Antiviral activity against HCMV VR1814 assessed as inhibition of viral infection in human MRC5 cells by RT-qPCR method | Human betaherpesvirus 5 | 1 | ALA3808290 | organism-based format | Scientific Literature | |
11. | ALA3813552 | Functional | Antiviral activity against HCMV VR1814 assessed as inhibition of viral infection in human ARPE19 cells by RT-qPCR method | Human betaherpesvirus 5 | 1 | ALA3808290 | organism-based format | Scientific Literature | |
12. | ALA3813553 | Functional | Antiviral activity against HCMV VR1814 infected in human ARPE19 cells after 72 hrs by cell-to-cell spread assay | Human betaherpesvirus 5 | 1 | ALA3808290 | organism-based format | Scientific Literature | |
13. | ALA3813554 | ADME | Metabolic stability of compound in rat hepatocytes relative to hepatic blood flow | Rattus norvegicus | 1 | ALA3808290 | cell-based format | Scientific Literature | |
14. | ALA3813555 | ADME | Clearance in rat relative to hepatic blood flow | Rattus norvegicus | 1 | ALA3808290 | organism-based format | Scientific Literature | |
15. | ALA3813556 | ADME | Half life of compound in rat | Rattus norvegicus | 1 | ALA3808290 | organism-based format | Scientific Literature | |
16. | ALA3813557 | ADME | Volume of distribution at steady state in rat | Rattus norvegicus | 1 | ALA3808290 | organism-based format | Scientific Literature | |
17. | ALA3813558 | ADME | Metabolic stability of compound in human hepatocytes relative to hepatic blood flow | Homo sapiens | 1 | ALA3808290 | cell-based format | Scientific Literature | |
18. | ALA3813559 | ADME | Oral bioavailability in rat | Rattus norvegicus | 1 | ALA3808290 | organism-based format | Scientific Literature |